Top 10 enhertu.com Competitors

trodelvy.com

Answers to FAQs on TRODELVY® (sacituzumab govitecan-hziy) treatment and patient concerns. See Important Facts & Important Warning.

daiichisankyo.com

daiichi sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world.

lorbrena.com

See risks and benefits. Visit the official Lorbrena® (lorlatinib) patient site to learn about clinical trial results.

keytruda.com

learn about keytruda® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers. visit the patient website.

ibrance.com

See risks and benefits. Learn about IBRANCE® (palbociclib) for the first line treatment of certain patients with HR+/HER2- Metastatic Breast Cancer.

xtandi.com

Watch patient testimonials to hear their experiences with XTANDI® (enzalutamide).

alunbrig.com

Please see Important Safety, Patient, and Prescribing Information.

phesgo.com

Learn about PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx), a combination treatment option for HER2-positive breast cancer that's given in minutes. See Full Safety, including most serious side effects, for more information.

ontada.com

Ontada®, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, was awarded a competitive contract with the U.S. Food and Drug Administration (FDA) to advance the use of real-world data (RWD) in the U.S. community oncology setting. The research aims to strengthen the scientific understanding of the natural history of rare cancers by leveraging Ontada’s community oncology footprint, unique RWD, and experience in real-world research (RWR).